Abstract
The mechanism of overproduction of aldosterone in primary aldosteronism is unclear. The intraadrenal renin-angiotensin system (RAS) has been suggested to possess the functional role of the synthesizing aldosterone and regulating blood pressure. In order to clarify the pathophysiological roles of adrenal RAS in aldosterone-producing adenoma (APA), we studied the expressions of the messenger RNAs (mRNAs) of renin, angiotensinogen, type 1 (AT1R) and type 2 angiotensin II receptor (AT2R), CYP11B1 (11β-hydroxylase gene) and CYP11B2 (aldosterone synthase gene) in 8 patients with angiotensin II-responsive (ATII-R) APA and compared them with the expressions of the same mRNAs in 8 patients with angiotensin II-unresponsive (ATII-U) APA. Quantification of the mRNA of each gene was done using a real-time polymerase chain reaction with specific primers. There were no significant differences between ATII-R APA and ATII-U APA in the mRNA levels of renin, angiotensinogen, AT1R, CYP11B1 and CYP11B2. The amount of AT2R mRNA was significantly higher in the patients with ATII-R APA than in those with ATII-U APA (p<0.05). These results may suggest that AT2R partially contributes to the overproduction of aldosterone in ATII-R APA.
Similar content being viewed by others
Article PDF
References
Ehrhart-Bornstein M, Hinson JP, Bornstein SR, Scherbaum WA, Vinson GP : Intraadrenal interactions in the regulation of adrenocortical steroidogenesis. Endocr Rev 1998; 19: 101–143.
Young WF : Primary aldosteronism-changing concepts in diagnosis and treatment. J Clin Endocrinol Metab 2003; 144: 2208–2213 ( Minireview).
Omura M, Saito J, Yamaguchi K, Kakuta Y, Nishikawa T : Prospective study on the prevalence of secondary hypertension among hypertensive patients visiting a general outpatient clinic in Japan. Hypertens Res 2004; 27: 193–202.
Takeda Y : Genetic alterations in patients with primary aldosteronism. Hypertens Res 2001; 24: 469–472.
Milliez P, Girerd X, Plouin P-F, et al: Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism. J Am Coll Cardiol 2005; 45: 1243–1248.
Brown G, Douglas J, Bravo E : Angiotensin II receptors and in vitro aldosterone responses of aldosterone-producing adenomas, adjacent non-tumorous tissue, and normal human adrenal glomerurosa. J Clin Endocrinol Metab 1980; 51: 718–723.
Cook MD, Phillips MI, Cook VI, Kimura B, Wilcox CS : Angiotensin II receptor subtypes on adrenal adenoma in primary aldosteronism. J Am Soc Nephrol 1993; 4: 111–116.
Chen YM, Wu KD, Hu-Tsai MI, Chu JS, Lai MK, Hsieh BS : Differential expression of type 1 angiotensin II receptor mRNA and aldosterone responsiveness to angiotensin in aldosterone-producing adenoma. Mol Cell Endocrinol 1999; 152: 47–55.
Takeda Y, Furukawa K, Inaba S, Miyamori I, Mabuchi H : Genetic analysis of aldosterone synthase in patients with idiopathic hyperaldosteronism. J Clin Endocrinol Metab 1999; 84: 1633–1637.
Takeda Y, Yoneda T, Demura M, Usukura M, Mabuchi H : Calcineurin inhibition attenuates mineralocorticoid-induced cardiac hypertrophy. Circulation 2002; 105: 677–679.
Nomura K, Toraya S, Horiba N, et al: Plasma aldosterone response to upright posture and angiotensin II infusion in aldosterone-producing adenoma. J Clin Endocrinol Metab 1992; 75: 323–327.
Gordon RD : Mineralocorticoid hypertension. Lancet 1994; 344: 240–243.
Biglieri EG, Schambelan M, Hirai J, Chang B, Brust N : The significance of elevated levels of plasma 18-hydroxycorticosterone in patients with primary aldosteronism. J Clin Endocrinol Metab 1979; 49: 87–91.
Endemann DH, Wolf K, Boeger CA, et al: Adrenal aldoste-rone biosynthesis is elevated in a model of chronic renal failure—role of local adrenal renin-angiotensin system. Nephron Physiol 2004; 97: 37–44.
Racz K, Pinet F, Gasc JM, Guyene TT, Corvol P : Coexpression of renin, angiotensinogen, and their messenger ribonucleic acids in adrenal tissue. J Clin Endocrinol Metab 1992; 75: 730–737.
Klemm SA, Ballantine DM, Gordon R, et al: The renin gene and aldosterone-producing adenomas. Kidney Int 1994; 46: 1591–1593.
Cook MD, Phillips MI, Cook VI, Kimura B, Wilcox CS : Angiotensin II receptor subtypes on adrenal adenoma in primary aldosteronism. J Am Soc Nephrol 1993; 4: 111–116.
Takeda Y, Usukura M, Yoneda T, et al: The expression of messenger RNA for ADP-ribosyl cyclase in aldosterone-producing adenomas. Clin Endocrinol 2005; 62: 504–508.
Lumbers ER : Angiotensin and aldosterone. Regul Pept 1999; 80: 91–100.
Nouet S, Nahmias C : Signal transduction from the angiotensin II AT2 receptor. Trends Endocrinol Metab 2000; 11: 1–6.
Mifune M, Sasamura H, Simizu-Horita R, Miyazaki H, Saruta T : Angiotensin II type 2 receptors stimulate collagen synthesis in cultured vascular smooth muscle cells. Hypertension 2000; 36: 845–850.
Cao Z, Dean R, Wu L, Casley D, Cooper ME : Role of angiotensin receptor subtypes in mesenteric vascular proliferation and hypertrophy. Hypertension 1999; 34: 408–414.
Levy BI, Benessiano J, Henrion D, et al: Chronic blockade of AT2-subtype receptors prevents the effect of angiotensin II on the rat vascular structure. J Clin Invest 1996; 98: 418–425.
Chan LY, Leung JC, Tang SC, Choy CB, Lai KN : Tubular expression of angiotensin II receptors and their regulation in IgA nephropathy. J Am Soc Nephrol 2005; 16: 2306–2317.
Tanabe A, Naruse M, Arai K, et al: Gene expression and roles of angiotensin II type 1 and type 2 receptors in human adrenals. Horm Metab Res 1998; 30: 490–495.
Naruse M, Tanabe A, Sato A, et al: Aldosterone breakthrough during angiotensin II receptor antagonist therapy in stroke-prone spontaneously hypertensive rats. Hypertension 2002; 40: 28–33.
Chen X, Li W, Yoshida H, et al: Targeting deletion of angiotensin 1B receptor gene in the mouse. Am J Physiol 1997; 272: F299–F304.
Falcon BK, Veerasingham SJ, Summers C, Raizada MK : Angiotensin II type 2 receptor-mediated gene expression profiling in human coronary artery endothelial cells. Hypertension 2005; 45: 692–697.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Oda, N., Takeda, Y., Zhu, A. et al. Pathophysiological Roles of the Adrenal Renin-Angiotensin System in Patients with Primary Aldosteronism. Hypertens Res 29, 9–14 (2006). https://doi.org/10.1291/hypres.29.9
Received:
Accepted:
Issue date:
DOI: https://doi.org/10.1291/hypres.29.9
Keywords
This article is cited by
-
Sporadic solitary aldosterone- and cortisol-co-secreting adenomas: endocrine, histological and genetic findings in a subtype of primary aldosteronism
Hypertension Research (2010)
-
Primary Aldosteronism: Diagnostic Accuracy of the Losartan and Captopril Tests
American Journal of Hypertension (2009)
